Canlyniadau Chwilio - Montserrat Domènech

  • Dangos 1 - 5 canlyniadau o 5
Mireinio'r Canlyniadau
  1. 1
    The R71G<i>BRCA1</i>is a founder Spanish mutation and leads to aberrant splicing of the transcript

    The R71G<i>BRCA1</i>is a founder Spanish mutation and leads to aberrant splicing of the transcript gan Ana Vega, Berta Campos, Brigitte Bressac–de Paillerets, Patricia M. Bond, Nicolas Janin, Fiona S. Douglas, Montserrat Domènech, Manel Baena, Carles Pericay, Carmen Alonso, Ángel Carracedo, Montserrat Baiget, Orland Dı́ez

    Cyhoeddwyd 2001
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy

    Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy gan Albert Font, Montserrat Domènech, Raquel Benítez, Marta Rava, Miriam Marqués, José Luis Ramírez, Sílvia Pineda, Sara Domínguez‐Rodríguez, J. Gago, Josep Badal, Cristina Carrato, Héctor López, Ariadna Quer, Daniel Castellano, Núria Malats, Francisco X. Real

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

    Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study gan Jorge Aparicio, Pablo Maroto, Xavier García del Muro, Josep Gumà, Alfonso Sánchez‐Muñoz, Mireia Margelí Vila, Montserrat Domènech, R. Bastús, António Fernández, M. López-Brea, J. Terrassa, Andrés Meana, Purificación Martínez del Prado, Javier Sastre, Juan J. Satrústegui, Regina Gironés, Lídia Robert, J.R. Germá

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?

    Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data? gan Àurea Navarro‐Sabaté, Rebeca Font, Josep Alfons Espinàs, Joaquím Fernández Solà, Fina Martínez‐Soler, Miguel Gil‐Gil, Gemma Viñas, Ariadna Tibau, María Borrell, Miguel Ángel Seguí, Mireia Margelí Vila, Sònia Servitja, Cristina Pérez, Montserrat Domènech, M. Nava, María José Sanches Marín, Sonia González, Josep M. Borràs

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients

    Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients gan Natàlia Jiménez, Marta García de Herreros, Òscar Reig, Mercedes Marín‐Aguilera, Caterina Aversa, Laura Ferrer‐Mileo, Samuel García-Esteve, Leonardo Rodríguez‐Carunchio, Isabel Trias, Albert Font, Alejo Rodríguez‐Vida, Miguel Ángel Climent, Sara Cros, Isabel Chirivella, Montserrat Domènech, Mariona Figols, Joan Carles, Cristina Suárez, D. Herrero Rivera, Enrique González‐Billalabeitia, Claudia Cívico, Núria Sala‐González, Vicenç Ruiz de Porras, María J. Ribal, Aleix Prat, Begoña Mellado

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: